Status | Study |
Not yet recruiting |
Study Name: Dietary Nitrate on Salivary Flow for Nasopharyngeal Carcinoma Patients Condition: Nasopharyngeal Carcinoma Date: 2016-07-23 Interventions: Dietary Supplement: Sodium nitrate |
Not yet recruiting |
Study Name: Donafenib Monotherapy for Previously Treated Metastatic Nasopharyngeal Carcinoma Condition: Nasopharyngeal Carcinoma Date: 2016-02-29 Interventions: Drug: Donafenib donafenib 200mg,bid Other Nam |
Active, not recruiting |
Study Name: Nasopharyngeal Carcinoma Post IMRT Condition: Nasopharyngeal Carcinoma Date: 2015-08-18 |
Completed |
Study Name: HepaSphere Interventional Therapy Using Digital Subtraction Angiography(DSA) for Nasopharyngeal Carcinoma Condition: Nasopharyngeal Carcinoma Date: 2015-08-12 Interventions: Procedure: interventional therapy nasopharyngeal carcinoma patients received HepaSphere interventional t |
Recruiting |
Study Name: The Role of Induction Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma in the Era of IMRT Condition: Nasopharyngeal Carcinoma Date: 2015-05-28 Interventions: Drug: Gemcitabine Experimental |
Recruiting |
Study Name: Maintenance Capecitabine Plus Best Supportive Care Versus Best Supportive Care for Metastatic Nasopharyngeal Carcinoma Condition: Nasopharyngeal Carcinoma Date: 2015-05-23 Interventions: Drug: capecitabine capecitabin |
Recruiting |
Study Name: The Effect of COX-2 Inhibitor on Radiosensitivity in Nasopharyngeal Carcinoma Condition: Nasopharyngeal Carcinoma Date: 2015-05-17 Interventions: Drug: Celecoxib Celecoxib 200m |
Completed |
Study Name: Retrospective Study About Nasopharyngeal Carcinoma at C. S. Parc Tauli Condition: Nasopharyngeal Carcinoma Date: 2014-07-23 |
Not yet recruiting |
Study Name: Dietary Nitrate on Plasma Nitrate Levels for Nasopharyngeal Carcinoma Patients Condition: Nasopharyngeal Carcinoma Date: 2014-01-21 Interventions: Dietary Supplement: nitrate supplementation |
Not yet recruiting |
Study Name: Endostar Combination With Chemotherapy for the Metastatic Nasopharyngeal Carcinoma Condition: Nasopharyngeal Carcinoma Date: 2012-05-28 Interventions: Drug: endostatin Gemcitabine 1.0g/m2 d1,8 cisplatin 80mg/m2 endostatin 15mg/d 14days/cycle *4cycles |